Blog

Jun 5, 2020

World’s first study of potential COVID-19 antibody treatment in humans

Posted by in category: biotech/medical

The first patients have been dosed in a study of LY-CoV555, the lead antibody from Lilly’s collaboration with AbCellera. See our blog at: https://www.futuretimeline.net/blog/2020/06/4-covid-19-antibodies.htm

Follow us on Twitter: https://twitter.com/future_timeline
Follow us on Instagram: https://www.instagram.com/ftimeline/
Follow us on Facebook: https://www.facebook.com/futuretimeline.net/
Follow us on Reddit: https://www.reddit.com/r/futuretimeline/

Comments are closed.